PGNY | Progyny, Inc.

Healthcare | Health Information Services | USA | NASD

Index	-	P/E	93.55	EPS (ttm)	0.43	Insider Own	0.80%	Shs Outstand	93.83M	Perf Week	3.33%
Market Cap	3.87B	Forward P/E	61.37	EPS next Y	0.66	Insider Trans	-68.45%	Shs Float	81.62M	Perf Month	7.41%
Income	43.10M	PEG	8.06	EPS next Q	0.10	Inst Own	95.40%	Short Float / Ratio	7.51% / 7.49	Perf Quarter	32.02%
Sales	873.10M	P/S	4.43	EPS this Y	-53.70%	Inst Trans	-1.63%	Short Interest	6.13M	Perf Half Y	24.98%
Book/sh	4.52	P/B	8.92	EPS next Y	39.79%	ROA	8.00%	Target Price	46.14	Perf Year	33.64%
Cash/sh	2.17	P/C	18.59	EPS next 5Y	11.60%	ROE	11.80%	52W Range	25.67 - 46.50	Perf YTD	29.44%
Dividend	-	P/FCF	35.49	EPS past 5Y	31.00%	ROI	7.80%	52W High	-13.29%	Beta	1.51
Dividend %	-	Quick Ratio	2.50	Sales past 5Y	74.50%	Gross Margin	22.10%	52W Low	57.07%	ATR	1.44
Employees	393	Current Ratio	2.50	Sales Q/Q	50.10%	Oper. Margin	4.40%	RSI (14)	64.53	Volatility	3.97% 3.75%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	254.80%	Profit Margin	4.90%	Rel Volume	0.79	Prev Close	40.94
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 08 AMC	Payout	0.00%	Avg Volume	817.78K	Price	40.32
Recom	1.70	SMA20	6.47%	SMA50	14.94%	SMA200	13.42%	Volume	649,035	Change	-1.51%

Date	Action	Analyst	Rating Change	Price Target Change
May-22-23	Initiated	BTIG Research	Buy	$50
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight	$44
Jan-05-23	Downgrade	SVB Leerink	Outperform → Mkt Perform	$34
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$55
Sep-07-22	Initiated	Truist	Buy	$56
Dec-02-21	Initiated	Jefferies	Buy	$60
Nov-22-21	Downgrade	Citigroup	Buy → Neutral	$60 → $64
Sep-30-21	Initiated	Berenberg	Buy	$81
Aug-12-21	Initiated	Barclays	Overweight	$64
Jun-02-21	Downgrade	Guggenheim	Buy → Neutral
Apr-29-21	Resumed	JP Morgan	Overweight	$65
Mar-10-21	Upgrade	BofA Securities	Neutral → Buy	$53
Jul-01-20	Initiated	SVB Leerink	Outperform	$35
Jun-02-20	Initiated	Guggenheim	Buy	$30
Nov-19-19	Initiated	SVB Leerink	Outperform	$28
Nov-19-19	Initiated	Piper Jaffray	Overweight	$33
Nov-19-19	Initiated	JP Morgan	Overweight	$26
Nov-19-19	Initiated	Goldman	Buy	$33
Nov-19-19	Initiated	Citigroup	Buy	$30

Show Previous Ratings

Jun-07-23 07:06AM	Progyny, Inc.'s (NASDAQ:PGNY) Intrinsic Value Is Potentially 99% Above Its Share Price (Simply Wall St.)
Jun-05-23 12:00PM	Progyny, Inc. to Present at Jefferies 2023 Healthcare Conference (GlobeNewswire)
May-24-23 06:51AM	Have $1,000? These 3 Stocks Could Be Bargain Buys for 2023 and Beyond. (Motley Fool)
May-17-23 12:45PM	Looking for a Growth Stock? 3 Reasons Why Progyny (PGNY) is a Solid Choice (Zacks)
12:20PM	Earnings Estimates Moving Higher for Progyny (PGNY): Time to Buy? (Zacks)
09:55AM	Loading…
09:55AM	How Much Upside is Left in Progyny (PGNY)? Wall Street Analysts Think 32.32% (Zacks)
May-09-23 06:49AM	Q1 2023 Progyny Inc Earnings Call (Thomson Reuters StreetEvents) +8.46%
May-08-23 05:35PM	Progyny (PGNY) Q1 Earnings and Revenues Surpass Estimates (Zacks)
04:33PM	Progyny: Q1 Earnings Snapshot (AP Finance)
04:03PM	Progyny, Inc. Announces First Quarter 2023 Results (GlobeNewswire)
May-04-23 01:26PM	Declining Stock and Decent Financials: Is The Market Wrong About Progyny, Inc. (NASDAQ:PGNY)? (Simply Wall St.)
May-02-23 12:00PM	Progyny, Inc. to Present at Bank of America Health Care Conference 2023 (GlobeNewswire)
Apr-27-23 05:35AM	4 Growth Stocks to Buy and Hold Forever (Motley Fool)
Apr-26-23 08:00PM	PGNY: Lowering target price to $36.00 (Argus Research)
Apr-24-23 12:00PM	Progyny, Inc. Announces Details for Its First Quarter 2023 Results Report (GlobeNewswire)
11:10AM	Loading…
Apr-19-23 11:10AM	Progyny and Fertility Matters Canada Honour Canadian Fertility Awareness Week with a Call to Increase Access to Family Building Care (GlobeNewswire)
Apr-18-23 09:00AM	Progyny and RESOLVE to Honor National Infertility Awareness Week® by Lighting the Empire State Building and Ringing the Nasdaq Stock Market Closing Bell (GlobeNewswire)
Apr-04-23 09:00AM	Progyny Appoints Janet Choi, M.D., as Chief Medical Officer (GlobeNewswire)
Mar-22-23 09:00AM	Childrens Hospital Association Selects Progyny as Exclusive Partner for Fertility and Family Building Benefits (GlobeNewswire)
Mar-20-23 12:00PM	Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum (GlobeNewswire)
Mar-14-23 09:00AM	Progyny Enhances Male Fertility Offering with the Expansion of its Reproductive Urologist Network (GlobeNewswire) +5.48%
Mar-11-23 08:45AM	Want $1 Million in Retirement? Invest $200,000 in These 3 Stocks and Wait a Decade (Motley Fool)
03:27AM	Progyny, Inc. (NASDAQ:PGNY) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-03-23 05:56PM	Why Shares of Progyny Rose 18.4% This Week (Motley Fool)
02:00AM	A Barrons Portfolio of Stocks Outperformed This Week. Alcoa, Progyny and Other Stocks That Popped. (Barrons.com)
Mar-01-23 09:00AM	Detroit Pistons Become First Professional Sports Team in the United States to Partner with Progyny to Provide Comprehensive, Value-Based Family Building Care (GlobeNewswire)
Feb-28-23 08:24AM	Target, Tesla and Zoom stocks rise; Workday shares fall over forecast, and more big movers (MarketWatch) +20.81%
Feb-27-23 06:45PM	Zoom Is Zooming, But This Health-Tech Stock Is Doing Even Better (Motley Fool)
05:35PM	Progyny (PGNY) Q4 Earnings and Revenues Beat Estimates (Zacks)
04:03PM	Progyny, Inc. Announces Fourth Quarter 2022 Results (GlobeNewswire)
08:04AM	Loading…
Feb-26-23 08:04AM	12 High Growth Healthcare Stocks to Buy (Insider Monkey)
Feb-13-23 04:44PM	Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2022 Results Report (GlobeNewswire)
Jan-30-23 12:10PM	Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report? (Zacks)
07:54AM	Investors in Progyny (NASDAQ:PGNY) have made a return of 27% over the past three years (Simply Wall St.)
Jan-25-23 04:16AM	Should You Retain Progyny (PGNY) Stock? (Insider Monkey)
Jan-19-23 08:28AM	Cardiovascular Systems (CSII) Global Sales Up, Margin Woe Stays (Zacks)
Jan-18-23 10:32AM	Edwards Lifesciences (EW) Gains From Innovation Amid Cost Woe (Zacks)
Jan-09-23 05:53PM	7 Stocks With a Forward P/E of 25 to Run Away From (InvestorPlace) +5.75%
08:00AM	Progyny to Discuss its Strong 2022 Financial Performance at Upcoming Investor Conference (GlobeNewswire)
Jan-02-23 09:12AM	Progyny (NASDAQ:PGNY) Is Doing The Right Things To Multiply Its Share Price (Simply Wall St.)
Dec-27-22 05:57AM	4 Unstoppable Multibaggers to Buy in 2023 and Hold for the Next Decade (Motley Fool)
Dec-16-22 11:40AM	ELV vs. PGNY: Which Stock Is the Better Value Option? (Zacks)
05:08AM	Zacks Industry Outlook Highlights Medpace, HealthEquity and Progyny (Zacks)
Dec-15-22 10:05AM	3 Medical Services Stocks to Buy Amid Industry Challenges (Zacks)
07:51AM	Is It Too Late To Consider Buying Progyny, Inc. (NASDAQ:PGNY)? (Simply Wall St.)
Nov-28-22 11:40AM	ELV vs. PGNY: Which Stock Should Value Investors Buy Now? (Zacks) +7.39%
08:16AM	Fertility manager Progyny stock gains as resumption of Menopur deliveries leads to raised guidance (MarketWatch)
08:00AM	Progyny Raises 2022 Financial Guidance (GlobeNewswire)
Nov-25-22 11:41AM	Progyny, Inc.'s (NASDAQ:PGNY) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? (Simply Wall St.)
Nov-23-22 10:20AM	Does Progyny (PGNY) Have High Growth Prospects? (Insider Monkey)
Nov-11-22 11:40AM	ELV or PGNY: Which Is the Better Value Stock Right Now? (Zacks)
Nov-09-22 06:26AM	Progyny Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.) -8.24%
Nov-08-22 09:55AM	Wall Street Analysts See a 64% Upside in Progyny (PGNY): Can the Stock Really Move This High? (Zacks)
Nov-04-22 05:40PM	Progyny Is Helping With Infertility. Why Its Stock Still Looks Like a Winner. (Barrons.com)
12:00PM	Progyny, Inc. to Present at Credit Suisse 31st Annual Healthcare Conference (GlobeNewswire)
Nov-03-22 05:35PM	Progyny (PGNY) Q3 Earnings and Revenues Top Estimates (Zacks)
04:01PM	Progyny, Inc. Announces Third Quarter 2022 Results (GlobeNewswire)
Nov-01-22 09:30AM	2 Unstoppable Growth Stocks to Buy in 2022 and Beyond (Motley Fool)
Oct-28-22 01:56PM	Is Progyny (PGNY) a Rapidly Growing Business? (Insider Monkey) +6.43%
Oct-21-22 11:40AM	ELV or PGNY: Which Is the Better Value Stock Right Now? (Zacks)
Oct-18-22 01:05PM	Progyny, Inc. Announces Details for Its Third Quarter 2022 Results Report (GlobeNewswire)
Oct-03-22 04:35AM	Should You Invest in Progyny (PGNY) Now? (Insider Monkey)
Sep-29-22 12:00PM	Progyny (PGNY) Upgraded to Buy: Here's What You Should Know (Zacks)
Sep-28-22 11:40AM	AMN or PGNY: Which Is the Better Value Stock Right Now? (Zacks)
Sep-12-22 12:47PM	Progyny, Inc.'s (NASDAQ:PGNY) Intrinsic Value Is Potentially 89% Above Its Share Price (Simply Wall St.)
Sep-09-22 11:40AM	MODV vs. PGNY: Which Stock Is the Better Value Option? (Zacks)
10:00AM	Progyny, Inc. to Present at the BofA Securities 2022 Global Healthcare Conference (GlobeNewswire)
Sep-06-22 03:00PM	Progyny Strengthens Board of Directors with Appointment of Healthcare Leader and Advocate (GlobeNewswire)
Sep-01-22 10:30AM	This Growth Stock Could Provide Big Long-Term Gains (Motley Fool)
08:51AM	10 Best Stocks Under $50 According to Hedge Funds (Insider Monkey)
Aug-31-22 09:55AM	Does Progyny (PGNY) Have the Potential to Rally 64% as Wall Street Analysts Expect? (Zacks)
Aug-24-22 11:40AM	MODV vs. PGNY: Which Stock Should Value Investors Buy Now? (Zacks)
Aug-23-22 06:19AM	Progyny (NASDAQ:PGNY) shareholders have lost 11% over 1 year, earnings decline likely the culprit (Simply Wall St.)
Aug-15-22 09:55AM	Can Progyny (PGNY) Climb 47% to Reach the Level Wall Street Analysts Expect? (Zacks)
Aug-08-22 11:40AM	AMN vs. PGNY: Which Stock Should Value Investors Buy Now? (Zacks) +8.34%
Aug-06-22 04:15AM	Barrons Stock Picks Had a Good Week. Progyny, Angi, and Other Stocks That Outperformed the Market. (Barrons.com)
Aug-05-22 11:16PM	ClearBridge Investments Observes Progyny, Inc. (PGNY) as Underpenetrated in its Market (Insider Monkey) +38.23%
Aug-04-22 06:05PM	Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates (Zacks) -8.54%
04:05PM	Progyny, Inc. Announces Second Quarter 2022 Results (GlobeNewswire)
Jul-27-22 08:00AM	Progyny is First Fertility Benefits Solution to Publish Outcomes with Independent Validation (GlobeNewswire)
Jul-26-22 09:53AM	Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY) (Simply Wall St.)
Jul-21-22 04:13PM	Progyny, Inc. Announces Details for Its Second Quarter 2022 Results Report (GlobeNewswire)
Jul-14-22 12:54PM	Molina Healthcare (MOH) to Buy My Choice Wisconsin for $150M (Zacks)
Jul-13-22 04:54PM	Encompass Health (EHC) to Build New Rehab Unit in Missouri (Zacks)
10:15AM	Why This Company Still Has a Long Runway for Growth (Motley Fool)
Jul-11-22 12:00PM	Progyny (PGNY) Upgraded to Buy: Here's Why (Zacks) -5.50%
Jul-08-22 06:13AM	What Is Progyny, Inc.'s (NASDAQ:PGNY) Share Price Doing? (Simply Wall St.)
Jun-24-22 06:00AM	CoDiagnostics, Inc. (CODX) Surges 5.6%: Is This an Indication of Further Gains? (Zacks)
Jun-22-22 09:39AM	Will Mednax's (MD) New Name Pediatrix Medical be Beneficial? (Zacks)
Jun-21-22 01:45PM	HCA Healthcare (HCA) Scraps Utah Buyout Post FTC's Roadblock (Zacks)
Jun-20-22 01:33PM	Centene (CNC) Raises 2022 Guidance, Ups Share Buyback Fund (Zacks)
Jun-17-22 08:41AM	Cigna (CI) Signs $3.5B Accelerated Share Buyback Agreements (Zacks)
Jun-16-22 04:07PM	Encompass Health (EHC) Forms JV With NCH Healthcare in Naples (Zacks)
Jun-15-22 02:58PM	Encompass Health (EHC) Plans to Distribute Enhabit Shares (Zacks)
Jun-14-22 10:13AM	HCA Healthcare's (HCA) Galen College Adds 8th New Facility (Zacks)
Jun-12-22 09:02AM	Declining Stock and Solid Fundamentals: Is The Market Wrong About Progyny, Inc. (NASDAQ:PGNY)? (Simply Wall St.)
Jun-10-22 11:40AM	AMN or PGNY: Which Is the Better Value Stock Right Now? (Zacks)
Jun-07-22 03:20PM	HCA Healthcare's (HCA) Utah Acquisition Faces Fed Roadblocks (Zacks)
09:11AM	Implied Volatility Surging for Progyny (PGNY) Stock Options (Zacks)
02:10AM	Is it Wise to Invest in Progyny (PGNY)? (Insider Monkey)

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Payson Norman	Director	Nov 23	Sale	56.29	200	11,258	580,656	Nov 26 04:34 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 07	Option Exercise	3.95	16,000	63,200	231,924	Jun 08 08:00 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 07	Sale	40.97	16,000	655,512	215,924	Jun 08 08:00 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 07	Sale	40.97	4,000	163,878	16,597	Jun 08 08:00 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 06	Option Exercise	3.95	16,000	63,200	231,924	Jun 07 06:22 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 06	Sale	41.01	16,000	656,086	215,924	Jun 07 06:22 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 06	Sale	41.01	4,000	164,021	20,597	Jun 07 06:22 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 05	Option Exercise	3.95	16,000	63,200	231,924	Jun 07 06:22 PM
Schlanger David J	Executive Chairman	Jun 05	Option Exercise	0.91	41,666	37,916	115,153	Jun 07 06:23 PM
Schlanger David J	Executive Chairman	Jun 05	Sale	40.00	41,666	1,666,824	73,487	Jun 07 06:23 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 05	Sale	40.00	16,000	640,057	215,924	Jun 07 06:22 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 05	Sale	40.00	4,000	160,014	24,597	Jun 07 06:22 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 02	Option Exercise	3.95	16,000	63,200	231,924	Jun 05 05:08 PM
Schlanger David J	Executive Chairman	Jun 02	Option Exercise	0.91	41,667	37,917	115,154	Jun 05 04:48 PM
Schlanger David J	Executive Chairman	Jun 02	Sale	38.68	41,667	1,611,680	73,487	Jun 05 04:48 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 02	Sale	38.67	16,000	618,720	215,924	Jun 05 05:08 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 02	Sale	38.67	4,000	154,680	28,597	Jun 05 05:08 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 01	Option Exercise	3.95	16,000	63,200	231,924	Jun 05 05:08 PM
Schlanger David J	Executive Chairman	Jun 01	Option Exercise	0.91	41,667	37,917	115,154	Jun 05 04:48 PM
Schlanger David J	Executive Chairman	Jun 01	Sale	37.55	41,667	1,564,431	73,487	Jun 05 04:48 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 01	Sale	37.55	16,000	600,850	215,924	Jun 05 05:08 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Jun 01	Sale	37.55	4,000	150,212	32,597	Jun 05 05:08 PM
GORDON KEVIN K	Director	May 24	Sale	38.24	1,410	53,918	12,354	May 26 05:03 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 16	Option Exercise	3.95	4,608	18,202	220,532	May 18 07:21 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 16	Sale	35.94	4,608	165,612	215,924	May 18 07:21 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 16	Sale	35.94	1,153	41,439	36,597	May 18 07:21 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 15	Option Exercise	3.95	32,000	126,400	247,924	May 16 05:29 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 15	Sale	36.24	32,000	1,159,680	215,924	May 16 05:29 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 15	Sale	36.24	8,000	289,920	31,655	May 16 05:29 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 12	Option Exercise	3.95	32,000	126,400	247,924	May 16 05:29 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 12	Sale	36.30	32,000	1,161,600	215,924	May 16 05:29 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 12	Sale	36.30	8,000	290,400	39,655	May 16 05:29 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 11	Option Exercise	3.95	32,000	126,400	247,924	May 12 04:21 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 11	Sale	36.49	32,000	1,167,579	215,924	May 12 04:21 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 11	Sale	36.49	8,000	291,895	47,655	May 12 04:21 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 10	Option Exercise	3.95	32,000	126,400	247,924	May 12 04:21 PM
Schlanger David J	Executive Chairman	May 10	Option Exercise	0.91	34,593	31,480	108,080	May 12 04:22 PM
Schlanger David J	Executive Chairman	May 10	Sale	37.72	34,593	1,304,978	73,487	May 12 04:22 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 10	Sale	37.74	32,000	1,207,541	215,924	May 12 04:21 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 10	Sale	37.74	8,000	301,885	55,655	May 12 04:21 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 09	Option Exercise	3.95	32,000	126,400	247,924	May 10 04:24 PM
Schlanger David J	Executive Chairman	May 09	Option Exercise	0.91	100,000	91,000	173,487	May 10 04:24 PM
Schlanger David J	Executive Chairman	May 09	Sale	37.68	100,000	3,768,135	73,487	May 10 04:24 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 09	Sale	37.70	32,000	1,206,324	215,924	May 10 04:24 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 09	Sale	37.70	8,000	301,581	63,655	May 10 04:24 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 08	Option Exercise	3.95	22,932	90,581	238,856	May 10 04:24 PM
Schlanger David J	Executive Chairman	May 08	Option Exercise	0.91	67,887	61,777	141,374	May 10 04:24 PM
Schlanger David J	Executive Chairman	May 08	Sale	35.11	67,887	2,383,513	73,487	May 10 04:24 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 08	Sale	35.09	22,932	804,684	215,924	May 10 04:24 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	May 08	Sale	35.09	5,733	201,171	77,750	May 10 04:24 PM
Schlanger David J	Executive Chairman	Apr 24	Option Exercise	0.91	10,224	9,304	83,711	Apr 25 04:58 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Apr 24	Option Exercise	3.95	1,857	7,335	217,781	Apr 25 04:59 PM
Schlanger David J	Executive Chairman	Apr 24	Sale	35.00	10,224	357,840	73,487	Apr 25 04:58 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Apr 24	Sale	35.00	1,857	64,995	215,924	Apr 25 04:59 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Apr 24	Sale	35.00	464	16,240	83,483	Apr 25 04:59 PM
Schlanger David J	Executive Chairman	Apr 21	Option Exercise	0.91	37,296	33,939	110,783	Apr 25 04:58 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Apr 21	Option Exercise	3.95	8,370	33,062	224,294	Apr 25 04:59 PM
Schlanger David J	Executive Chairman	Apr 21	Sale	35.01	37,296	1,305,733	73,487	Apr 25 04:58 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Apr 21	Sale	35.01	8,370	293,034	215,924	Apr 25 04:59 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Apr 21	Sale	35.01	2,093	73,276	83,947	Apr 25 04:59 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 08	Option Exercise	3.95	1,041	4,112	224,942	Mar 10 04:30 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 08	Sale	35.00	1,041	36,435	223,901	Mar 10 04:30 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 08	Sale	35.00	260	9,100	86,040	Mar 10 04:30 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 07	Option Exercise	3.95	22,151	87,496	246,052	Mar 08 04:42 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 07	Sale	35.29	22,151	781,709	223,901	Mar 08 04:42 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 07	Sale	35.29	5,538	195,436	86,300	Mar 08 04:42 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 06	Option Exercise	3.95	32,000	126,400	255,901	Mar 08 04:42 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 06	Sale	35.81	32,000	1,145,920	223,901	Mar 08 04:42 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 06	Sale	35.81	8,000	286,480	91,838	Mar 08 04:42 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 03	Option Exercise	3.95	32,000	126,400	255,901	Mar 06 04:37 PM
Schlanger David J	Executive Chairman	Mar 03	Option Exercise	0.91	41,666	37,916	117,834	Mar 06 04:36 PM
Schlanger David J	Executive Chairman	Mar 03	Sale	36.26	41,666	1,510,809	76,168	Mar 06 04:36 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 03	Sale	36.25	32,000	1,160,000	223,901	Mar 06 04:37 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 03	Sale	36.26	8,000	290,080	99,838	Mar 06 04:37 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 02	Option Exercise	3.95	32,000	126,400	255,901	Mar 06 04:37 PM
Schlanger David J	Executive Chairman	Mar 02	Option Exercise	0.91	41,667	37,917	117,835	Mar 06 04:36 PM
Schlanger David J	Executive Chairman	Mar 02	Sale	36.11	41,667	1,504,710	76,168	Mar 06 04:36 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 02	Sale	36.12	32,000	1,155,694	223,901	Mar 06 04:37 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 02	Sale	36.12	8,000	288,924	107,838	Mar 06 04:37 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 01	Option Exercise	3.95	32,000	126,400	255,901	Mar 02 04:37 PM
Schlanger David J	Executive Chairman	Mar 01	Option Exercise	0.91	41,667	37,917	117,835	Mar 02 04:39 PM
Schlanger David J	Executive Chairman	Mar 01	Sale	37.69	41,667	1,570,303	76,168	Mar 02 04:39 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 01	Sale	37.61	32,000	1,203,496	223,901	Mar 02 04:37 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Mar 01	Sale	37.61	8,000	300,874	115,838	Mar 02 04:37 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Feb 28	Option Exercise	3.95	32,000	126,400	255,900	Mar 02 04:37 PM
Schlanger David J	Executive Chairman	Feb 28	Option Exercise	0.91	67,891	61,781	144,059	Mar 02 04:39 PM
Schlanger David J	Executive Chairman	Feb 28	Sale	36.85	67,891	2,501,705	76,168	Mar 02 04:39 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Feb 28	Sale	36.84	31,999	1,178,790	223,901	Mar 02 04:37 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Feb 28	Sale	36.84	8,000	294,707	123,838	Mar 02 04:37 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Feb 06	Option Exercise	3.95	2,305	9,105	226,205	Feb 08 04:21 PM
Schlanger David J	Executive Chairman	Feb 06	Option Exercise	0.91	5,824	5,300	81,992	Feb 08 04:20 PM
Schlanger David J	Executive Chairman	Feb 06	Sale	35.26	5,824	205,354	76,168	Feb 08 04:20 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Feb 06	Sale	35.28	2,305	81,320	223,900	Feb 08 04:21 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Feb 06	Sale	35.28	576	20,321	131,838	Feb 08 04:21 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Feb 03	Option Exercise	3.95	32,000	126,400	255,900	Feb 06 05:10 PM
Schlanger David J	Executive Chairman	Feb 03	Option Exercise	0.91	100,000	91,000	176,168	Feb 06 05:02 PM
Schlanger David J	Executive Chairman	Feb 03	Sale	35.54	100,000	3,554,374	76,168	Feb 06 05:02 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Feb 03	Sale	35.55	32,000	1,137,734	223,900	Feb 06 05:10 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Feb 03	Sale	35.55	8,000	284,432	132,414	Feb 06 05:10 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Feb 02	Option Exercise	3.95	32,000	126,400	255,900	Feb 06 05:10 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PGNY | Progyny, Inc.

Upgrade your FINVIZ experience